Use of a novel polymorphism in the hsgk1 gene in the diagnosis of hypertonia and use of the sgk gene family in the diagnosis and therapy of the long QT syndrome

Details for Australian Patent Application No. 2004209609 (hide)

Owner Lang, F.

Inventors Lang, Florian; Busjahn, Andreas

Agent Watermark

Pub. Number AU-A-2004209609

PCT Pub. Number WO2004/070057

Priority 103 05 213.5 07.02.03 DE

Filing date 5 February 2004

Wipo publication date 19 August 2004

International Classifications

C12Q 001/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

1 September 2005 PCT application entered the National Phase

  PCT publication WO2004/070057 Priority application(s): WO2004/070057

3 September 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004209618-Use of oxalate deficient aspergillus niger strains for producing a polypeptide

2004209599-Oligomeric compounds for the modulation of ras expression